Literature DB >> 11393569

A history of growth hormone injection devices.

E Fidotti1.   

Abstract

In the early 1960s, growth hormone (GH) deficiency was treated by intramuscular injection of GH extracted from human pituitary glands. Since then, there have been many advances in treatment encompassing the route of administration, the injection product and the injection device. This review considers the advances in injection device that have already taken place and how they have benefited the patient, particularly in terms of reduced pain and improved convenience. In the future, needle-free injection techniques and depot formulations of GH are likely to offer alternatives to daily subcutaneous injections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393569     DOI: 10.1515/jpem.2001.14.5.497

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.

Authors:  Nancy A Nickman; Sandra W Haak; Jaewhan Kim
Journal:  BMC Nurs       Date:  2010-04-08

2.  Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.

Authors:  Kevin C J Yuen; Rakesh Amin
Journal:  Patient Prefer Adherence       Date:  2011-03-10       Impact factor: 2.711

3.  Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use.

Authors:  Anita Hokken-Koelega; Alexandra Keller; Viatcheslav Rakov; Stefan Kipper; Jovanna Dahlgren
Journal:  ISRN Endocrinol       Date:  2011-09-20

Review 4.  Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.

Authors:  Yunpeng Cai; Mingxin Xu; Minglu Yuan; Zhenguo Liu; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2014-07-25

5.  Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.

Authors:  Chris Brearley; Anthony Priestley; James Leighton-Scott; Michel Christen
Journal:  BMC Clin Pharmacol       Date:  2007-10-08

6.  Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults.

Authors:  Andreas M Pleil; Feyza Darendeliler; Helmuth G Dörr; Katherine Hutchinson; Hartmut A Wollmann
Journal:  Med Devices (Auckl)       Date:  2014-04-11

7.  Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel Membranes.

Authors:  Thomas Geninatti; R Lyle Hood; Giacomo Bruno; Priya Jain; Eugenia Nicolov; Arturas Ziemys; Alessandro Grattoni
Journal:  Materials (Basel)       Date:  2015-08-13       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.